Related Experiment Videos
Leveraging artificial intelligence to predict non-adherence to pediatric immunization schedules: a systematic review
Robin Rey1, Arnaud G L'Huillier2,3, Laure F Pittet2,4
1Platform of Clinical Research in Pediatrics, Gynecology and Obstetrics, Department of Women, Children and Adolescent Health, Geneva University Hospitals, Geneva, Switzerland. robin.rey@hug.ch.
European Journal of Pediatrics
|May 15, 2026
Summary
Artificial intelligence (AI) can predict children
Area of Science:
- Public Health
- Medical Informatics
- Epidemiology
Background:
- Geographic, sociodemographic, and medical factors influence immunization schedule adherence.
- Identifying at-risk individuals enables targeted interventions to improve vaccination coverage.
- Artificial intelligence (AI) offers novel approaches to uncover complex predictive patterns.
Purpose of the Study:
- To systematically review studies utilizing AI for predicting childhood immunization non-adherence.
- To identify key predictors and assess the performance and validation of AI models.
Main Methods:
- Systematic literature review of studies using AI to predict immunization non-adherence in children.
- Searches conducted in PubMed, Embase, and Web of Science without restrictions.
- Risk of bias assessed using PROBAST+AI; study characteristics, AI methods, and performance extracted.
Main Results:
- Twelve studies were included, with most from low- and middle-income countries using routine immunization data.
- AI models generally showed high performance (accuracy/AUC >80% in 9/12 studies).
- Key predictors included maternal factors (prenatal care) and child-related factors (previous immunization history).
Conclusions:
- AI shows significant potential for identifying individuals at risk of vaccine non-adherence.
- Lack of external validation limits current real-world applicability and raises concerns about overfitting.
- Demographic health surveys are a valuable resource for external validation of AI models.
Related Concept Videos
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Vaccinations
Overview